Ulrike Meyer-Lindemann: Can Physical Activity Protect against Stress-Induced Vascular Inflammation
Ulrike Meyer-Lindemann, Research Fellow at Massachusetts General Hospital, shared a post on LinkedIn about a recent article co-authored by her and her colleagues, published in JACC: Basic to Translational Science, adding:
“Excited to share that our paper has been published today in JACC: Basic to Translational Science!
Mental stress is a major, but often overlooked, risk factor for cardiovascular disease.
In this study, we investigated whether physical activity can protect against stress-induced vascular inflammation.
Using mouse models, we found that regular physical activity blunts the systemic stress response and enhances resilience by dampening stress-induced endothelial activation and the influx of circulating inflammatory leukocytes, ultimately reducing vascular inflammation.
To test this in a real-world setting, we conducted a proof-of-concept study in humans using an emotionally intense soccer match as a stressor during UEFA EURO 2024.
Physically active individuals showed a markedly milder stress-induced immune response.
In short: exercise may help ‘shield’ the vasculature from the harmful effects of acute stress.
Grateful to have worked with an incredible team on this project, and especially thankful to my mentor Hendrik Sager.
Many thanks to Deutsche Herzstiftung e.V. for supporting my work.”
Title: Exercise Reverses Mental Stress–Induced Vascular Inflammation and Builds Stress Resilience
Authors:Ulrike Meyer-Lindemann, Karina Borbil, Marius Schwab, Aldo Moggio, Rui Shen, M. Amin Sharifi, Tan An Dang, Viktoria Schories, Raphael Rottenkolber, Svenja Rapelius, Julia Hinterdobler, Carina Mauersberger, Moritz von Scheidt, Lars Maegdefessel, Henning Wackerhage, Karsten Köhler, Egija Berga-Švītiņa, Baiba Vilne, Michael Hristov, Christian Weber, Sabine Steffens, Cameron S. McAlpine, Heribert Schunkert, Thorsten Kessler, Hendrik B. Sager

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke